{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fenofibric+acid", "query": { "intervention": "Fenofibric acid" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 24, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fenofibric+acid&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-16T00:40:33.658Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00639158", "title": "Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyslipidemias", "Coronary Heart Disease", "Combined (Atherogenic) Dyslipidemia", "Mixed Dyslipidemia" ], "interventions": [ { "name": "ABT-335", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "atorvastatin", "type": "DRUG" }, { "name": "ezetimibe", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 543, "start_date": "2008-02", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-06-13", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 118, "location_summary": "Birmingham, Alabama • Columbiana, Alabama • Hueytown, Alabama + 107 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Columbiana", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" }, { "city": "Ozark", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00639158" }, { "nct_id": "NCT01472380", "title": "A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "efavirenz", "type": "DRUG" }, { "name": "fenofibric acid 105 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mutual Pharmaceutical Company, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 30, "start_date": "2011-11", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2012-08-01", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01472380" }, { "nct_id": "NCT00960856", "title": "Four Arm Food Effect Study of Fenofibric Acid Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Fenofibric Acid 105 mg Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mutual Pharmaceutical Company, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 40, "start_date": "2007-11", "completion_date": "2007-11", "has_results": true, "last_update_posted_date": "2009-10-20", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00960856" }, { "nct_id": "NCT00491530", "title": "A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Mixed Dyslipidemia" ], "interventions": [ { "name": "ABT-335", "type": "DRUG" }, { "name": "rosuvastatin calcium", "type": "DRUG" }, { "name": "simvastatin", "type": "DRUG" }, { "name": "atorvastatin calcium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 310, "start_date": "2007-06", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2012-01-20", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 1, "location_summary": "Abbott Park, Illinois", "locations": [ { "city": "Abbott Park", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00491530" }, { "nct_id": "NCT00680017", "title": "30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyslipidemia", "Kidney Disease" ], "interventions": [ { "name": "ABT-335 plus rosuvastatin", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 280, "start_date": "2008-06", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-10-03", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 102, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Madison, Alabama + 93 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Madison", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00680017" }, { "nct_id": "NCT00681525", "title": "A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pharmacokinetics" ], "interventions": [ { "name": "ABT-335", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Ezetimibe", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 18, "start_date": "2008-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-10-19", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00681525" }, { "nct_id": "NCT01356290", "title": "Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Medulloblastoma Recurrent", "Ependymoma Recurrent", "ATRT Recurrent", "Rare CNS Tumor Recurrent" ], "interventions": [ { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Thalidomide", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Fenofibric acid", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Temozolomide (TMZ)", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medical University of Vienna", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "19 Years", "sex": "ALL", "summary": "Up to 19 Years" }, "enrollment_count": 232, "start_date": "2014-04", "completion_date": "2030-04", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 4, "location_summary": "Chicago, Illinois • Boston, Massachusetts • Grand Rapids, Michigan + 1 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01356290" }, { "nct_id": "NCT00300430", "title": "Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyslipidemia", "Coronary Heart Disease", "Mixed Dyslipidemia" ], "interventions": [ { "name": "ABT-335 and rosuvastatin calcium", "type": "DRUG" }, { "name": "ABT-335 and atorvastatin calcium", "type": "DRUG" }, { "name": "ABT-335 and simvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1911, "start_date": "2006-09", "completion_date": null, "has_results": true, "last_update_posted_date": "2009-07-23", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 1, "location_summary": "North Chicago, Illinois", "locations": [ { "city": "North Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00300430" }, { "nct_id": "NCT00463606", "title": "A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypercholesterolemia", "Dyslipidemia" ], "interventions": [ { "name": "ABT-335 and rosuvastatin calcium", "type": "DRUG" }, { "name": "ABT-335", "type": "DRUG" }, { "name": "rosuvastatin calcium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 760, "start_date": "2007-04", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2012-10-03", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 168, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Ozark, Alabama + 135 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00463606" }, { "nct_id": "NCT00487136", "title": "Interaction Between ABT-335, Rosuvastatin and Warfarin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Warfarin", "type": "DRUG" }, { "name": "warfarin plus ABT-335 plus rosuvastatin 5 mg", "type": "DRUG" }, { "name": "warfarin plus ABT-335 plus rosuvastatin 20 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "18 Years to 50 Years · Male only" }, "enrollment_count": 45, "start_date": "2007-06", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2012-09-28", "last_synced_at": "2026-09-16T00:40:33.658Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00487136" } ] }